289 related articles for article (PubMed ID: 31450926)
1. Dual Glycation-Inflammation Modulation, DPP-IV and Pancraetic Lipase Inhibitory Potentials and Antiproliferative Activity of Novel Fluoroquinolones.
Arabiyat S; Kasabri V; Al-Hiari Y; Al-Masri I; Alalawi S; Bustanji Y
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2503-2514. PubMed ID: 31450926
[TBL] [Abstract][Full Text] [Related]
2. Antilipase and antiproliferative activities of novel fluoroquinolones and triazolofluoroquinolones.
Arabiyat S; Kasabri V; Al-Hiari Y; Bustanji YK; Albashiti R; Almasri IM; Sabbah DA
Chem Biol Drug Des; 2017 Dec; 90(6):1282-1294. PubMed ID: 28639358
[TBL] [Abstract][Full Text] [Related]
3.
Hallaq T; Al-Hiari Y; Kasabri V; AlBashiti R; AlAlawi S; Telfah A
Anticancer Agents Med Chem; 2022; 22(19):3304-3321. PubMed ID: 35570520
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Properties of 7,8-Ethylene Diamine Chelator-Lipophilic Fluoroquinolone Derivatives Against Colorectal Cancer Cell Lines.
Khaleel S; Al-Hiari Y; Kasabri V; Haddadin R; Albashiti R; Al-Zweri M; Bustanji Y
Anticancer Agents Med Chem; 2022; 22(5):1012-1028. PubMed ID: 34165411
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative Activities of Lipophililic Fluoroquinolones- Based Scaffold Against a Panel of Solid and Liquid Cancer Cell Lines.
Qashou E; Al-Hiari Y; Kasabri V; AlBashiti R; AlAlawi S; Telfah A; AlHadid A
Asian Pac J Cancer Prev; 2022 May; 23(5):1529-1537. PubMed ID: 35633535
[TBL] [Abstract][Full Text] [Related]
6. Discovery of triazole-based uracil derivatives bearing amide moieties as novel dipeptidyl peptidase-IV inhibitors.
Deng X; Han L; Zhou J; Zhang H; Li Q
Bioorg Chem; 2017 Dec; 75():357-367. PubMed ID: 29096096
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel human dipeptidyl peptidase-IV inhibitors of natural origin (part I): virtual screening and activity assays.
Guasch L; Ojeda MJ; González-Abuín N; Sala E; Cereto-Massagué A; Mulero M; Valls C; Pinent M; Ardévol A; Garcia-Vallvé S; Pujadas G
PLoS One; 2012; 7(9):e44971. PubMed ID: 22984596
[TBL] [Abstract][Full Text] [Related]
8. Exploration of DPP-IV inhibitors with a novel scaffold by multistep in silico screening.
Uchida T; Wakasugi M; Kitamura T; Yamamoto T; Asakura M; Fujiwara R; Itoh T; Fujii H; Hirono S
J Mol Graph Model; 2018 Jan; 79():254-263. PubMed ID: 29274572
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of aminocoumarin derivatives as DPP-IV inhibitors and anticancer agents.
Soni R; Soman SS
Bioorg Chem; 2018 Sep; 79():277-284. PubMed ID: 29783098
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Biological Evaluation, and QPLD Studies of Piperazine Derivatives as Potential DPP-IV Inhibitors.
Khalaf RA; Jarad HA; Al-Qirim T; Sabbah D
Med Chem; 2021; 17(9):937-944. PubMed ID: 32940185
[TBL] [Abstract][Full Text] [Related]
11. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel benzyl-substituted (S)-phenylalanine derivatives as potent dipeptidyl peptidase 4 inhibitors.
Liu Y; Si M; Tang L; Shangguan S; Wu H; Li J; Wu P; Ma X; Liu T; Hu Y
Bioorg Med Chem; 2013 Sep; 21(18):5679-87. PubMed ID: 23938053
[TBL] [Abstract][Full Text] [Related]
13. DPP-IV Inhibitory Potentials of Flavonol Glycosides Isolated from the Seeds of
Kim BR; Kim HY; Choi I; Kim JB; Jin CH; Han AR
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103438
[TBL] [Abstract][Full Text] [Related]
14. Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo.
Jung E; Kim J; Kim SH; Kim S; Cho MH
Eur J Pharmacol; 2014 Dec; 744():98-102. PubMed ID: 25448307
[TBL] [Abstract][Full Text] [Related]
15. Rapid Identification of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides from Ruditapes philippinarum Hydrolysate.
Liu R; Zhou L; Zhang Y; Sheng NJ; Wang ZK; Wu TZ; Wang XZ; Wu H
Molecules; 2017 Oct; 22(10):. PubMed ID: 29027968
[TBL] [Abstract][Full Text] [Related]
16. Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents.
Savateev K; Fedotov V; Butorin I; Eltsov O; Slepukhin P; Ulomsky E; Rusinov V; Litvinov R; Babkov D; Khokhlacheva E; Radaev P; Vassiliev P; Spasov A
Eur J Med Chem; 2020 Jan; 185():111808. PubMed ID: 31683103
[TBL] [Abstract][Full Text] [Related]
17. Newly Substituted Anilino-Fluoroquinolones with Proliferation Inhibition Potential against a Panel of Cancer Cell Lines.
Salih MAF; Al-Hiari Y; Kasabri V; Darwish R; Abumansour H; Bourghli L; Al Alawi S; Albashiti R
Asian Pac J Cancer Prev; 2022 Jul; 23(7):2507-2521. PubMed ID: 35901360
[TBL] [Abstract][Full Text] [Related]
18. Ephedrine as a lead compound for the development of new DPP-IV inhibitors.
Ojeda-Montes MJ; Ardid-Ruiz A; Tomás-Hernández S; Gimeno A; Cereto-Massagué A; Beltrán-Debón R; Mulero M; Garcia-Vallvé S; Pujadas G; Valls C
Future Med Chem; 2017 Dec; 9(18):2129-2146. PubMed ID: 29172693
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and anti-diabetic activity of triazolotriazine derivatives as dipeptidyl peptidase-4 (DPP-4) inhibitors.
Patel BD; Bhadada SV; Ghate MD
Bioorg Chem; 2017 Jun; 72():345-358. PubMed ID: 28302310
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Structural Characterization and Docking Studies of Sulfamoyl- Phenyl Acid Esters as Dipeptidyl Peptidase-IV Inhibitors.
Khalaf RA; Sabbah D; Al-Shalabi E; Al-Sheikh I; Albadawi G; Abu Sheikha G
Curr Comput Aided Drug Des; 2018; 14(2):142-151. PubMed ID: 29521244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
